UROVANT SCIENCES LTD's ticker is UROV and the CUSIP is G9381B108. A total of 41 filers reported holding UROVANT SCIENCES LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $868,000 | +58.4% | 53,828 | -8.3% | 0.00% | – |
| Q3 2020 | $548,000 | -5.7% | 58,699 | -0.6% | 0.00% | – |
| Q2 2020 | $581,000 | +315.0% | 59,070 | +289.9% | 0.00% | – |
| Q1 2020 | $140,000 | -38.6% | 15,150 | +3.1% | 0.00% | – |
| Q4 2019 | $228,000 | +74.0% | 14,700 | +6.3% | 0.00% | – |
| Q3 2019 | $131,000 | -3.7% | 13,833 | -19.4% | 0.00% | – |
| Q2 2019 | $136,000 | +22.5% | 17,164 | +55.8% | 0.00% | – |
| Q1 2019 | $111,000 | – | 11,020 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|